The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126849102 12684910 2 F 20160227 20160826 20160825 20160909 EXP FR-TEVA-686675ROM TEVA 21.19 YR M Y 75.00000 KG 20160909 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126849102 12684910 1 PS ETOPOSIDE TEVA 20 mg/mL ETOPOSIDE 1 Intravenous drip 390 MILLIGRAM DAILY; Y 74284 390 MG SOLUTION FOR INFUSION QD
126849102 12684910 2 SS LEVACT 2.5 mg/mL BENDAMUSTINE HYDROCHLORIDE 1 Intravenous drip 390 MILLIGRAM DAILY; Y 0 390 MG QD
126849102 12684910 3 SS CYTARABINE SANDOZ 100 mg/mL CYTARABINE 1 Intravenous drip 780 MILLIGRAM DAILY; Y 0 390 MG SOLUTION FOR INJECTION BID
126849102 12684910 4 SS ALKERAN MELPHALAN 1 Intravenous (not otherwise specified) 270 MILLIGRAM DAILY; Y 0 270 MG QD
126849102 12684910 5 C ONDANSETRON ACCORD 2 mg/mL ONDANSETRON 1 0 SOLUTION FOR INJECTION
126849102 12684910 6 C EMEND APREPITANT 1 0
126849102 12684910 7 C METHYLPREDNISOLONE MYLAN METHYLPREDNISOLONE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126849102 12684910 3 Hodgkin's disease
126849102 12684910 4 Hodgkin's disease
126849102 12684910 5 Prophylaxis of nausea and vomiting
126849102 12684910 6 Prophylaxis of nausea and vomiting
126849102 12684910 7 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
126849102 12684910 HO
126849102 12684910 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126849102 12684910 Bone marrow failure
126849102 12684910 Off label use
126849102 12684910 Pyrexia
126849102 12684910 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126849102 12684910 1 20160218 20160221 0
126849102 12684910 2 20160216 20160217 0
126849102 12684910 3 20160218 20160221 0
126849102 12684910 4 20160222 20160222 0